Latest research
Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.
Top papers this month · This week's roundup
Trending topics
Dose-response meta-analysis of 89 cohorts (5,875,364 people with type 2 diabetes): SBP showed a J-shaped association with all-cause mortality; BP was linearly or monotonically associated with most cardiovascular and renal outcomes.
Meta-analysisn = 5,875,364
Wang et al. Blood Pressure Levels and Outcomes in Type 2 Diabetes: Dose-Response Meta-Analysis of 5.87 Million Cohort ParticipantsMeta-analysis of 237 population-based studies (1,251,682 IBD patients): in Crohn's disease, perianal disease was more common in Asian (24%) than White (14%) or Hispanic (13%) patients; no similar differences in ulcerative colitis.
Meta-analysisn = 1,251,682
Halim et al. Phenotypic Differences in Inflammatory Bowel Diseases Across Race, Ethnicity, and Geography: A Systematic Review of 237 Population-Based StudiesMeta-analysis of 50 studies (21,680 patients with giant cell arteritis): pooled prevalence of diplopia was 7.15%; diplopia with sixth (abducens) nerve involvement was 1.41%, third nerve 0.96% and fourth nerve 0.30%.
Meta-analysisn = 21,680
Dhivagaran et al. Prevalence of diplopia among giant cell arteritis patients: a systematic review and meta-analysisMeta-analysis of 77 placebo-controlled RCTs (16,416 participants): dual orexin receptor antagonists increased subjective total sleep time by 18.91 min but did not improve sleep quality, and raised somnolence risk (RR 2.91).
Meta-analysisn = 16,416
Stefanou et al. The effect of Dual Orexin Receptor Antagonists on sleep: a systematic review and pairwise meta-analysisMeta-analysis of 5 RCTs (13,245 patients with recent myocardial infarction): colchicine vs placebo did not significantly reduce MACE (8.2% vs 9.3%; RR 0.83, 95% CI 0.66-1.04) and did not increase adverse events.
Meta-analysisn = 13,245
Moiz et al. Colchicine in Patients With Recent Myocardial Infarction: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsSystematic review of 14 observational studies (9036 participants) found adults with insomnia had reduced gut microbial diversity and altered composition vs healthy controls, with lower Faecalibacterium and Lachnospira and higher Blautia in meta-analyses.
Meta-analysisn = 9,036
Chen et al. The association between gut microbiota and insomnia: A systematic review and meta-analysisMeta-analysis of 10 RCTs (7,847 patients) with advanced ovarian cancer: anti-PD-1/PD-L1 agents did not significantly improve progression-free survival vs control (HR 0.98, 95% CI 0.85-1.12), first-line or recurrent, nor in PD-L1-positive, BRCA or HRD groups.
Meta-analysisn = 7,847
Vida et al. Immunotherapy with anti-PD-1 or PD-L1 in advanced ovarian cancer: A meta-analysis of randomized trialsMeta-analysis of 34 RCTs (7486 patients): paclitaxel-coated femoropopliteal devices were associated with higher long-term all-cause mortality vs control (13.6% vs 11.3% crude; HR 1.18), with excess risk peaking in years 1-2 (HR 1.45).
Meta-analysisn = 7,486
Katsanos et al. Editor's Choice - Dynamic Risk of Death following Application of Paclitaxel Coated Devices in the Femoropopliteal Artery: A Contemporary Meta-analysis of Randomised Controlled TrialsMeta-regression of 15 RCTs (6,814 patients) in multiple sclerosis: treatment effects on serum/plasma NfL were moderately associated with effects on new/enlarging T2 lesions (R2 0.42), relapse rate (R2 0.33) and disability worsening (R2 0.30), but not brain volume change.
Meta-analysisn = 6,814
Pretzsch et al. Neurofilament light chain as a surrogate candidate for disease activity in multiple sclerosis (LUMINOUS)-A meta-regression of randomized controlled trialsMeta-analysis of 12 observational studies (5,158 adults) of AF ablation: pulsed-field vs thermal ablation was associated with more biomarker-defined haemolysis (LDH +63.79 U/L) but similar AKI (3.5% vs 3.1%; RR 1.14, 95% CI 0.42-3.12), and less major bleeding.
Meta-analysisn = 5,158
Kilic et al. Hemolysis and renal safety of pulsed-field vs thermal ablation for atrial fibrillation: A systematic review and meta-analysis